HCV Genotype 1b
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Investigation of Erlotinib as an HCV Entry Inhibitor (NCT01835938) | University Hospital, Strasbourg, France | 2013-05-01 |
Track HCV Genotype 1b automatically
Every clearance here is in the API, with alerts when new ones post.